Clinical Characteristics and Long-Term Outcomes of Adrenal Tumors in Children and Adolescents
Experimental and Clinical Endocrinology & Diabetes · 01.10.2023 · 131 (10) · 515-522
DOI: 10.1055/a-2127-9292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.10.2023. Verfasst von Ja Hye Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Adrenal Cortex Neoplasms, Adrenocortical Adenoma, Cushing Syndrome, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF), Korean government (Ministry of Science and ICT).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Adrenal tumors are generally rare in children and can be a part of familial cancer syndrome. This research was conducted to examine the clinical outcomes, histopathological results, and genetic etiologies of adrenal tumors in children and adolescents.
Methods
Thirty-one children and adolescents with adrenal tumors were included. Data on clinical outcomes and endocrine and radiologic results were retrospectively analyzed. Molecular analysis was conducted in select patients according to their phenotype and family history.
Results
The median age at diagnosis was 7.9 years (range: 0.8−17.8 years) with 5.1±1.8 cm of maximum tumor diameter. Adrenal adenoma (n=7), carcinoma (n=5), borderline (n=2), isolated micronodular adrenocortical disease (n=2), pheochromocytoma (n=8), paraganglioma (n=3), and ganglioneuroma (n=4) are all pathological diagnoses. The most common presenting symptom was excess production of adrenocortical hormones (n=15), including virilization and Cushing syndrome. Non-functioning adrenocortical tumors were found in a patient with congenital adrenal hyperplasia. Genetic etiologies were identified in TP53 (n=5), VHL (n=4), and PRKACA (n=1). Patients with mutations in TP53 were young (1.5±0.5 years) and had large masses (6.1±2.3 cm).
Conclusions
This study describes clinical outcomes and the pathological spectrum of adrenal tumors in children and adolescents. Adrenocortical tumors mostly presented with an excess of the adrenocortical hormone. Patients with genetic defects presented at a young age and large size of tumors, necessitating genetic testing in patients at a young age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Medical Genetics Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Förderung
- National Research Foundation of Korea (NRF)
- Korean government (Ministry of Science and ICT)
Zitieren
APA
Kim, J. H., Choi, Y., Hwang, S., Yoon, J. H., Kim, G. H., Yoo, H. W., & Choi, J. H. (2023). Clinical Characteristics and Long-Term Outcomes of Adrenal Tumors in Children and Adolescents. Experimental and Clinical Endocrinology & Diabetes, 131(10), 515-522. https://doi.org/10.1055/a-2127-9292
Vancouver
Kim JH, Choi Y, Hwang S, Yoon JH, Kim GH, Yoo HW, et al. Clinical Characteristics and Long-Term Outcomes of Adrenal Tumors in Children and Adolescents. Experimental and Clinical Endocrinology & Diabetes. 2023;131(10):515-522. doi:10.1055/a-2127-9292
BibTeX
@article{Kim2023,
author = {Kim, Ja Hye and Choi, Yunha and Hwang, Soojin and Yoon, Ji-Hee and Kim, Gu-Hwan and Yoo, Han-Wook and Choi, Jin-Ho},
title = {Clinical Characteristics and Long-Term Outcomes of Adrenal Tumors in Children and Adolescents},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2023},
volume = {131},
number = {10},
pages = {515--522},
doi = {10.1055/a-2127-9292}
}
EUVIMED